Nature’s Sunshine Products (NASDAQ:NATR) Issues Quarterly Earnings Results

Nature’s Sunshine Products (NASDAQ:NATRGet Free Report) issued its quarterly earnings data on Thursday. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.20 by $0.10, FiscalAI reports. Nature’s Sunshine Products had a net margin of 4.07% and a return on equity of 14.36%. The business had revenue of $122.89 million during the quarter, compared to analyst estimates of $122.15 million.

Here are the key takeaways from Nature’s Sunshine Products’ conference call:

  • Nature’s Sunshine reported a strong Q1 with $122.9 million in net sales (up 9% YoY), GAAP net income of $5.1 million ($0.28/share), and adjusted EBITDA up 33% to $14.6 million.
  • Digital momentum is a primary growth driver: North America digital sales rose 42% YoY, new digital customers increased 60%, and autoship subscriptions now represent 48% of website sales, improving retention and lifetime value.
  • Regional performance was broad-based: APAC grew 7% (China +40% in Q1 but management cautioned this pace is unlikely to repeat), Japan/Korea benefited from a skincare launch, and Europe grew 9% aided by better product availability despite Ukraine-related risks.
  • Gross margin improved 116 basis points to 73.2% (management expects ~73% average for 2026) driven by logistics, manufacturing efficiency, sourcing and pricing actions, while the balance sheet shows $87.6 million in cash and zero debt.
  • The company reiterated 2026 guidance of $500–515 million in sales and $50–54 million in adjusted EBITDA while planning measured technology and go-to-market investments (CTO hire, ERP/AI work, consultant app) that will temper near-term EBITDA growth but aim to support a long-term vision to reach $1 billion in sales and a 15% EBITDA margin.

Nature’s Sunshine Products Price Performance

NATR stock traded down $1.69 during trading on Thursday, hitting $24.55. 79,012 shares of the stock traded hands, compared to its average volume of 69,422. Nature’s Sunshine Products has a 1 year low of $12.97 and a 1 year high of $28.14. The firm’s 50 day moving average is $25.65 and its two-hundred day moving average is $22.97. The stock has a market cap of $429.87 million, a price-to-earnings ratio of 23.16 and a beta of 0.95.

Insider Activity at Nature’s Sunshine Products

In other news, CAO Jonathan David Lanoy sold 4,000 shares of the firm’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $24.70, for a total transaction of $98,800.00. Following the sale, the chief accounting officer owned 46,405 shares of the company’s stock, valued at $1,146,203.50. This trade represents a 7.94% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Daniel C. Norman sold 15,383 shares of the firm’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $24.52, for a total transaction of $377,191.16. Following the sale, the executive vice president directly owned 55,693 shares in the company, valued at approximately $1,365,592.36. The trade was a 21.64% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 38,899 shares of company stock valued at $951,206. 3.10% of the stock is owned by insiders.

Institutional Trading of Nature’s Sunshine Products

A number of institutional investors have recently made changes to their positions in the stock. Dimensional Fund Advisors LP boosted its holdings in shares of Nature’s Sunshine Products by 2.2% during the 3rd quarter. Dimensional Fund Advisors LP now owns 913,791 shares of the company’s stock valued at $14,181,000 after acquiring an additional 20,037 shares during the last quarter. Vanguard Group Inc. boosted its holdings in shares of Nature’s Sunshine Products by 15.3% during the 3rd quarter. Vanguard Group Inc. now owns 803,104 shares of the company’s stock valued at $12,464,000 after acquiring an additional 106,688 shares during the last quarter. Kennedy Capital Management LLC boosted its holdings in shares of Nature’s Sunshine Products by 14.6% during the 3rd quarter. Kennedy Capital Management LLC now owns 675,764 shares of the company’s stock valued at $10,488,000 after acquiring an additional 86,128 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Nature’s Sunshine Products by 3.3% during the 4th quarter. Renaissance Technologies LLC now owns 524,097 shares of the company’s stock valued at $11,310,000 after acquiring an additional 16,900 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in shares of Nature’s Sunshine Products by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 360,546 shares of the company’s stock worth $7,782,000 after buying an additional 1,980 shares during the last quarter. Hedge funds and other institutional investors own 79.40% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have commented on NATR. DA Davidson upped their price objective on shares of Nature’s Sunshine Products from $23.00 to $33.00 and gave the stock a “buy” rating in a report on Thursday, March 12th. Canaccord Genuity Group increased their price target on shares of Nature’s Sunshine Products from $22.00 to $29.00 and gave the stock a “buy” rating in a research note on Tuesday, March 10th. Finally, Weiss Ratings upgraded shares of Nature’s Sunshine Products from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, March 20th. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $31.00.

Read Our Latest Stock Report on Nature’s Sunshine Products

About Nature’s Sunshine Products

(Get Free Report)

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.

Featured Stories

Earnings History for Nature's Sunshine Products (NASDAQ:NATR)

Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.